KR20100040964A - 신규 간암 마커 - Google Patents

신규 간암 마커 Download PDF

Info

Publication number
KR20100040964A
KR20100040964A KR1020107005174A KR20107005174A KR20100040964A KR 20100040964 A KR20100040964 A KR 20100040964A KR 1020107005174 A KR1020107005174 A KR 1020107005174A KR 20107005174 A KR20107005174 A KR 20107005174A KR 20100040964 A KR20100040964 A KR 20100040964A
Authority
KR
South Korea
Prior art keywords
hdgf
liver cancer
antibody
glu
blood
Prior art date
Application number
KR1020107005174A
Other languages
English (en)
Korean (ko)
Inventor
히데지 나카무라
요우이치 야부우치
야스카즈 오모토
토요키 모리
마사히로 무라구치
케이코 오가
후사코 이와타
카오리 무라타
Original Assignee
가꼬우호우징 효고 이카다이가쿠
오츠카 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가꼬우호우징 효고 이카다이가쿠, 오츠카 세이야쿠 가부시키가이샤 filed Critical 가꼬우호우징 효고 이카다이가쿠
Publication of KR20100040964A publication Critical patent/KR20100040964A/ko

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
KR1020107005174A 2007-08-10 2008-08-07 신규 간암 마커 KR20100040964A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007209544 2007-08-10
JPJP-P-2007-209544 2007-08-10

Publications (1)

Publication Number Publication Date
KR20100040964A true KR20100040964A (ko) 2010-04-21

Family

ID=40350685

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107005174A KR20100040964A (ko) 2007-08-10 2008-08-07 신규 간암 마커

Country Status (7)

Country Link
US (1) US20110281284A1 (ja)
EP (1) EP2187216B1 (ja)
JP (1) JP5553603B2 (ja)
KR (1) KR20100040964A (ja)
CN (1) CN101796415B (ja)
ES (1) ES2392312T3 (ja)
WO (1) WO2009022632A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103245787B (zh) * 2012-02-01 2016-01-20 浙江大学 一种肝癌衍生生长因子检测试剂盒的制备方法
AU2014399919B2 (en) * 2014-07-02 2019-10-24 Dragon Victory Development Ltd. Specific biomarker set for non-invasive diagnosis of liver cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0241830A3 (en) * 1986-04-08 1990-01-10 The General Hospital Corporation Hepatoma-derived growth factor
JP2003180368A (ja) * 2001-12-19 2003-07-02 Pharma Design Inc 癌患者に対する放射線治療の有効性の予測方法
EP1631682A1 (en) * 2003-06-04 2006-03-08 Agency for Science, Technology and Research Differentially regulated hepatocellular carcinoma genes and uses thereof
EP1978985A2 (en) * 2005-12-23 2008-10-15 Board Of Regents Of The University Of Texas System Anti-hyperproliferative therapies targeting hdgf

Also Published As

Publication number Publication date
EP2187216A4 (en) 2011-03-02
WO2009022632A1 (ja) 2009-02-19
EP2187216A1 (en) 2010-05-19
EP2187216B1 (en) 2012-09-26
US20110281284A1 (en) 2011-11-17
CN101796415B (zh) 2014-03-12
JP5553603B2 (ja) 2014-07-16
CN101796415A (zh) 2010-08-04
JPWO2009022632A1 (ja) 2010-11-18
ES2392312T3 (es) 2012-12-07

Similar Documents

Publication Publication Date Title
JP5439176B2 (ja) Ｔｄｐ−４３凝集物に特異的に結合する抗体
AU2015254257B2 (en) Anti-MUC1 antibody or antigen-binding fragment of same, and use thereof
CN105793439B (zh) 以生物样品进行的针对igfbp7的具有改进的性能的测定
KR20050108389A (ko) 모노클로날 항체 및 이것을 생산하는 하이브리도마
EP2754672B1 (en) Antibody capable of binding to specific region of periostin, and method of measuring periostin using the same
CN107108733B (zh) 抗活性型gip抗体
US20220268761A1 (en) Therapy monitoring under treatment with an anti-adrenomedullin (adm) binder
CN107001453B (zh) 结合人p53线性表位的抗体及其诊断应用
KR20110000548A (ko) 신장암의 진단 또는 검출을 위한 조성물 및 방법
JP3259768B2 (ja) 腎疾患の検査方法
EP2860250B1 (en) Method for detecting cancer, and antibody capable of recognizing pancreas-specific ribonuclease 1
KR101338517B1 (ko) 인간 간-카르복실에스터라제 １을 특이적으로 인식하는 단일클론 항체, 상기 항체를 생산하는 하이브리도마 세포주 및 이의 용도
WO2012165926A2 (ko) 항-ａｔｉｃ 자가면역항체를 포함하는 간암 진단 마커 및 이의 항원을 포함하는 간암 진단용 조성물
KR20100040964A (ko) 신규 간암 마커
JP2008203041A (ja) ホスファチジルセリン特異的ホスホリパーゼａ１測定方法および検査試薬
CN113832132B (zh) 一种烙铁头svmp蛋白特异性短肽、抗烙铁头svmp蛋白抗体和蛇伤检测试剂盒
JPWO2009044561A1 (ja) 抗ｐｒｏＮＴ／ＮＭＮモノクローナル抗体
JP2010536715A (ja) Ｎｅｓｆａｔｉｎ−１特異的抗体およびその用途、ならびにＮｅｓｆａｔｉｎ特異的抗体およびその用途
JP6141257B2 (ja) Ｃ１ｑ−アディポネクチン複合体及びその利用
JP2010254682A (ja) 抗フィブロネクチンフラグメントモノクローナル抗体

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application